Bangladesh producing experimental drugs for Covid-19

Sun Online Desk

7th April, 2020 04:20:56 printer

Bangladesh producing experimental drugs for Covid-19

Thousands of people across the world are dying of Covid-19 every day without proper treatment as there is no specific medicine for such viral disease yet. All countries—small or large, rich or poor—of the world have been engaged in search of appropriate drugs for this menace. Researches have been going on. Experimental medicines are being made.

Pharmaceutical companies in Bangladesh also come forward to make medicines for the viral disease Covid-19. Bangladeshi companies are just producing experimental medicines that are being tested in different countries for treating corona patients.

According to Directorate General of Drug Administration (DGDA) sources, Eskayef (SK+F) Pharmaceuticals, Beacon Pharmaceuticals, Beximco Pharmaceuticals, Ziska Pharmaceuticals, Incepta Pharmaceuticals among others are producing medicines for Covid-19.

It was also reported that the DGDA has given approval to domestic companies to produce several medicines. Besides, Bangladesh National Guideline for Covid-19 had included some medicines to its policy.

Eskayef (SK+F) Pharmaceuticals has already made Hydroxychloroquine, Food and Drug Administration (FDA) of the USA has already given approval to emergency use of this drug for Covid-19 cases. Within very short time it is going to produce Favipiravir, Oseltamivir and Ivermectin like medicine.

“SK+F Pharmaceuticals has been closely working with Bangladesh Society of Medicine and Directorate General of Drug Administration (DGDA) to provide effective medicines to our people during such critical situation in the country,” said Simeen Hossain, Managing Director and CEO of the company.

Meanwhile, Beximco Pharmaceuticals has claimed that they are also producing medicines and storing them so that immediate supply could be done if the government wants.

Rabbur Reza, chief operating officer of the organisation, said, “Different countries are testing different drugs. Except Remdesivir, we produced all of them and stored so that we can supply to the government if anyone is proven effective and get approval. ”

Besides, Beacon Pharmaceuticals, renowned for making Cancer medicine, has made Favipiravir. Japan’s Fuji Company made this drug for the treatment of Ebola virus-infected patients. Later, China benefited from applying this medicine to prevent coronavirus.

Beacon Pharma's Managing Director Mohammed Ebadul Karim said, “We brought Active Pharmaceuticals Ingredient (API) from China. If the medicine will be found effective we will go for commercial production.”

However, no official statement from the DGDA has been made yet. But being an LDC country, Bangladesh has the opportunity to make medicines without having intellects rights, said Golam Kibria, former director of the DGDA.